| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |